Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.-Reference-Cited by-同舟云学术

Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist.

Published:1987-05-02 Issue:6580 Volume:294 Page:1129-1129
ISSN:0959-8138
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Anderson J V,Coupe M O,Morris J A,Hodgson H J,Bloom S R

Publisher

BMJ

Subject

General Earth and Planetary Sciences,General Environmental Science,General Engineering

Reference4 articles.

1. A highly selective and potent antagonist at peripheral neuronal 5-hydroxy tryptamine receptors;Donatsch, P.; Engel, G.; Richardson, B.P.; Stadler, P.A.;BrJ Pharmacol,1984

2. Identification ofserotonin M-receptor sub-types and their specific blockade by a new class of drugs;Richardson, B.P.; EngeIG, Donatsch; P, StadIeirPA;Natue,1985

3. Two kinds of tryptamine receptors;Gaddum, J.H.; Picarelli, Z.P.;Brj Pharmacol,1957

4. Management of carcinoid tumours of the gastrointestinal tract;Welch, J.P.; Malt, R.A.;Surg Gvnecol Obstet,1977

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CSTI-300 (SMP-100); a Novel 5-HT3Receptor Partial Agonist with Potential to Treat Patients with Irritable Bowel Syndrome or Carcinoid Syndrome;Journal of Pharmacology and Experimental Therapeutics;2020-02-26

2. Oral Ondansetron Offers Effective Antidiarrheal Activity for Carcinoid Syndrome Refractory to Somatostatin Analogs;The Oncologist;2018-08-31

3. NANETS Consensus Guideline for the Diagnosis and Management of Neuroendocrine Tumors;Pancreas;2010-08

4. Role of serotonin in gastrointestinal motility and irritable bowel syndrome;Clinica Chimica Acta;2009-05

5. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications;Alimentary Pharmacology & Therapeutics;2007-03-31